Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.3 INR | -4.33% | -4.33% | -22.34% |
Valuation
Fiscal Period: Marzo | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 302.6 | 254.1 | 85.45 | 115.6 | 110.6 | 73.57 |
Enterprise Value (EV) 1 | 539 | 552.9 | 379 | 454.5 | 521.1 | 424.1 |
P/E ratio | 17 x | 11.2 x | 6.84 x | -4.04 x | -2.66 x | -4.28 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.42 x | 0.32 x | 0.13 x | 0.28 x | 0.38 x | 0.38 x |
EV / Revenue | 0.76 x | 0.7 x | 0.59 x | 1.09 x | 1.79 x | 2.21 x |
EV / EBITDA | 5.6 x | 5.21 x | 4.83 x | 15.1 x | 168 x | -14.5 x |
EV / FCF | -9.87 x | -8.76 x | 22.3 x | -15 x | -7.81 x | 13.3 x |
FCF Yield | -10.1% | -11.4% | 4.48% | -6.65% | -12.8% | 7.54% |
Price to Book | 1.72 x | 1.3 x | 0.41 x | 0.64 x | 0.79 x | 0.6 x |
Nbr of stocks (in thousands) | 9,102 | 11,097 | 11,097 | 11,097 | 11,097 | 11,097 |
Reference price 2 | 33.25 | 22.90 | 7.700 | 10.42 | 9.970 | 6.630 |
Announcement Date | 8/23/18 | 9/7/19 | 12/14/20 | 9/7/21 | 9/21/22 | 9/9/23 |
Income Statement Evolution (Annual data)
Fiscal Period: Marzo | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 713.6 | 787.4 | 641.9 | 415.7 | 291.2 | 191.5 |
EBITDA 1 | 96.3 | 106.2 | 78.53 | 30.08 | 3.106 | -29.24 |
EBIT 1 | 73.78 | 83.41 | 60.23 | 13.84 | -6.61 | -37.46 |
Operating Margin | 10.34% | 10.59% | 9.38% | 3.33% | -2.27% | -19.56% |
Earnings before Tax (EBT) 1 | 24.23 | 28.06 | 17.21 | -27.48 | -52.23 | -22.99 |
Net income 1 | 17.87 | 20.65 | 12.49 | -28.58 | -41.66 | -17.18 |
Net margin | 2.5% | 2.62% | 1.95% | -6.88% | -14.31% | -8.97% |
EPS 2 | 1.960 | 2.046 | 1.126 | -2.580 | -3.754 | -1.550 |
Free Cash Flow 1 | -54.62 | -63.11 | 16.98 | -30.21 | -66.74 | 31.99 |
FCF margin | -7.65% | -8.02% | 2.65% | -7.27% | -22.92% | 16.71% |
FCF Conversion (EBITDA) | - | - | 21.62% | - | - | - |
FCF Conversion (Net income) | - | - | 135.91% | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 8/23/18 | 9/7/19 | 12/14/20 | 9/7/21 | 9/21/22 | 9/9/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 236 | 299 | 294 | 339 | 411 | 351 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 2.454 x | 2.813 x | 3.738 x | 11.27 x | 132.2 x | -11.99 x |
Free Cash Flow 1 | -54.6 | -63.1 | 17 | -30.2 | -66.7 | 32 |
ROE (net income / shareholders' equity) | 12.4% | 11.1% | 6.13% | -14.6% | -26% | -13.1% |
ROA (Net income/ Total Assets) | 8.03% | 7.73% | 5.51% | 1.32% | -0.65% | -4.21% |
Assets 1 | 222.7 | 267.2 | 226.9 | -2,169 | 6,422 | 407.9 |
Book Value Per Share 2 | 19.40 | 17.70 | 18.90 | 16.30 | 12.60 | 11.00 |
Cash Flow per Share 2 | 7.860 | 1.920 | 1.890 | 1.840 | 1.100 | 0.1400 |
Capex 1 | 50 | 25.7 | 7.63 | 1.92 | 0.91 | 0.14 |
Capex / Sales | 7.01% | 3.26% | 1.19% | 0.46% | 0.31% | 0.07% |
Announcement Date | 8/23/18 | 9/7/19 | 12/14/20 | 9/7/21 | 9/21/22 | 9/9/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-22.34% | 971K | |
-10.90% | 58.77B | |
+63.81% | 45.88B | |
+9.40% | 36.43B | |
-0.03% | 31.06B | |
+7.25% | 19.42B | |
+15.10% | 16.72B | |
+4.25% | 13.35B | |
-7.05% | 12.74B | |
-23.61% | 12.21B |
- Stock Market
- Equities
- ASYL6 Stock
- Financials Advance Syntex Limited